Where's the HIV Glossary?

The HIV Glossary formerly hosted on our site has been removed.

 

If you think you may have been infected with HIV/AIDS, please find a place to get a free, confidential HIV test.

 


HIV counselor in front of magnet board

HIV Info

Of the more than one million people estimated to be living with HIV in the United States, one in five don't know they're infected. The best way to fight HIV is to know your status.


If you think you may have been infected with HIV/AIDS, we encourage you to get a free, confidential HIV test.

Have questions about HIV/AIDS? We have answers to Frequently Asked Questions.

HIV stands for the Human Immunodeficiency Virus, and is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).  It is a virus that attacks the immune system. 

Over time, and without treatment, HIV gradually destroys the body's defenses against disease, leaving it vulnerable to many infections and cancers that do not normally develop.

AIDS is a late stage of HIV disease.  By the time of an AIDS diagnosis, HIV has already seriously damaged the body's immune system.  Often, a person living with AIDS will already have had life-threatening infections or cancers. 

Learn more about acquiring HIV, testing for HIV, and HIV treatment options.

Switch on your HIV Smarts with BETA

The Bulletin of Experimental Treatments for AIDS is your bright and brainy source on new developments in HIV prevention, evolving approaches to HIV treatment, and strategies for living well with the virus.

Latest BETA News

Dolutegravir Shows Promise as Part of First-Line HIV Therapy

Dolutegravir Shows Promise as Part of First-Line HIV Therapy

Jean-Michel Molina and colleagues reported this month in The Lancet HIV superiority of the integrase inhibitor dolutegravir (Tivicay) when compared to a boosted-protease inhibitor regimen of darunavir (Prezista) plus ritonavir … Read More

Supervisor Wiener: Reclassifying HIV Drugs as “Specialty” is Discriminatory

Supervisor Wiener: Reclassifying HIV Drugs as “Specialty” is Discriminatory

A hearing held on March 25, 2015 at a San Francisco City and County Budget and Finance Committee called attention to the insurance company practice of reclassifying HIV medications as … Read More

CROI 2015: Hepatitis C—Both the Good News and Bad

CROI 2015: Hepatitis C—Both the Good News and Bad

Attendees of last month’s 2015 Conference on Retroviruses and Opportunistic Infections (CROI) heard good news about nearly 100% cure rates for HIV/HCV coinfected people using new interferon-free hepatitis C treatment. … Read More

Shock & Kill: Progress in HIV Cure Research

Shock & Kill: Progress in HIV Cure Research

A new class of latency activator, a TLR7 agonist—used to “shock and kill” HIV-infected cells—has shown promise when tested in animals and represents an exciting development in the HIV cure … Read More

Early AIDS in San Francisco: Insights from a Ward 86 Founding Physician

Early AIDS in San Francisco: Insights from a Ward 86 Founding Physician

An article published last month in The San Francisco Examiner shares the compelling story of Dr. Paul Volberding, an AIDS treatment specialist who’s been treating AIDS patients since the earliest … Read More

Misogyny in Fag Space: How to Have a Dick Without Being a Dick

Misogyny in Fag Space: How to Have a Dick Without Being a Dick

“Oh, lordy have mercy! A vagina just walked in the room.” “There goes the neighborhood,” Dustin1 snarked, scrunching his face in agreement with Eric’s comment before prancing off to the … Read More

Dr. Robert Grant: What Does Ipergay Tell Us About PrEP and ‘Seasons of Risk’?

Dr. Robert Grant: What Does Ipergay Tell Us About PrEP and ‘Seasons of Risk’?

Much-anticipated efficacy results from a French study of intermittent PrEP were announced at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) at the end of February. Although PrEP experts … Read More

See more articles on the BETA Blog...